Dr. Alexis Ogdie updates me on her #ACR23 must knows for SpA/PsA patients @RheumNow https://t.co/hFLzLtmcSl

Went into more depth on this great topic of IBD in SpA on @RheumNow #ACR23 Should we be screening SpA patients with fecal calprotectin to look for undiagnosed SpA? https://t.co/TmXhm2MEfO https://t.co/SWJSqF5pkW

#irAE Baseline immune suppression does NOT protect against worsening synovitis flares when using check point inhibitors in Pts with established #inflammatory #arthritis #ACRbest #ACR23 @ACRheum @RheumNow abst1075 Data from #CanRIO database https://t.co/lOCf8Tbgta

#ACR23 Abs #2199 large RL study: SEC retention rates after 4 yrs approx. 50% in axSpA and PsA pts. Bio-naïve pts had higher retention, remission & response rates than pts with prior b/tsDMARD exposure, particularly in axSpA. https://t.co/Eq5BwILK3D @rheumnow https://t.co/slho6yAwtQ

SPARTAN referral recommendations for axSpA #ACR23 Abs #2214 https://t.co/VQedpNynpv support Abs #2207 https://t.co/8RB0D4ef7i findings discussing that non-rheums are less aware of IBP components/asking about them in CBP pts. @rheumnow https://t.co/23oUONsMfb

The presence of antibodies to 4 UH-axSpA peptides was confirmed in the Belgian Inflammatory Arthritis and Spondylitis (Be-Giant) cohort of newly diagnosed axSpA patients and could be of added value for axSpA diagnosis. #ACR23 Abs #2210 https://t.co/fV4PPbWF01 @rheumnow

A#1403 #ACR23 @RheumNow 17% of 1st degree relatives of AS pts have MRI-defined sacroiliitis Study of 100 subjects w FHx AS - 13/100: new dx of AxSpA, 7 w radiographic changes - 4/100: Sacroiliitis without back pain - 1 periph SpA - 12 met clinical ASAS classification but not dx https://t.co/V7LCbaDXBe

17% of 1st degree relatives AS pts had MRI- defined sacroiliitis, however not all of them were diagnosed w/ SpA due to absence of back pain. 25% w/ 1st degree AS relative met the classification criteria for SpA #ACR23 Abs #1403 https://t.co/W1T9ZqD4o1 @rheumnow https://t.co/DnaNSLiqfU

Does NSAID use = CKD? Large Korean study on CKD in ankylosing spondylitis pts showed risk of CKD associated with comorbidities. Long term NSAID use not associated with increased risk of CKD. @RheumNow #ACR23 Abs#1394 https://t.co/m3kYI30gBc